Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT01418820
Eligibility Criteria:
Inclusion Criteria:
* lesion of the tractus opticus or of the visual cortex
* lesion age \> 6 months
* stable visual field defect with residual vision
Exclusion Criteria:
* electric or electronic implants, e.g. heart pacer
* any metal artefacts in the head
* Epilepsy
* Auto-immune diseases in acute stage
* mental diseases, e.g. schizophrenia etc.
* diabetic retinopathy
* addictive diseases
* blood pressure above 160/100 mmHg
* instable or high level of intraocular pressure above 27 mmHg
* retinitis pigmentosa
* pathological nystagmus
* presence of an un-operated tumor or tumor relapse (patients with non-progressive tumor are eligible if study participation is recommended by medical authorities)
* focal findings in EEG or photosensitivity (patients with single seizure more than 10 yrs ago may participate)
* recurrent transitional ischemic attacks after stroke
* arteriosclerosis of large blood vessels with stenosis \>75%
* severe coronary heart disease (CHD)
* unstable angina pectoris
* diabetes with blood glucose level \> 9 mmol/l
* myocard infarct/ cardiomyopathy
* ventricular fibrillation
* risk of vascular thrombosis
* pregnant or breast-feeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01418820
Study Brief:
Protocol Section:
NCT01418820